81.8%; HR, 0.91; 95% CI, 0.72â€“1.13;P= .38).[18][Level of evidence A1] Similar findings were reported from the EORTC trial (NCT00002851).
Women with a centrally or medially located primary tumor with or without axillary node involvement, or an externally located tumor with axillary involvement, were randomly assigned to receive whole-breast or thoracic-wall radiation therapy in addition to regional nodal irradiation or not.
Breast-conserving surgery was performed for 76.1% of the study population, and the remaining participants underwent mastectomy.
No improvement in OS was seen at 10 years among patients who underwent regional nodal irradiation, compared with patients who did not undergo regional nodal radiation (82.3% vs.